BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 30421045)

  • 21. Effects of time interval between primary melanoma excision and sentinel node biopsy on positivity rate and survival.
    Oude Ophuis CM; van Akkooi AC; Rutkowski P; Voit CA; Stepniak J; Erler NS; Eggermont AM; Wouters MW; Grünhagen DJ; Verhoef CK
    Eur J Cancer; 2016 Nov; 67():164-173. PubMed ID: 27669503
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel and accurate computer model of melanoma prognosis for patients staged by sentinel lymph node biopsy: comparison with the American Joint Committee on Cancer model.
    Callender GG; Gershenwald JE; Egger ME; Scoggins CR; Martin RC; Schacherer CW; Edwards MJ; Urist MM; Ross MI; Stromberg AJ; McMasters KM
    J Am Coll Surg; 2012 Apr; 214(4):608-17; discussion 617-9. PubMed ID: 22342785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors associated with sentinel lymph node status and prognostic role of completion lymph node dissection for thick melanoma.
    Boada A; Tejera-Vaquerizo A; Ribero S; Puig S; Moreno-Ramírez D; Quaglino P; Osella-Abate S; Cassoni P; Malvehy J; Carrera C; Pigem R; Barreiro-Capurro A; Requena C; Traves V; Manrique-Silva E; Fernández-Orland A; Ferrandiz L; García-Senosiain O; Fernández-Figueras MT; Ferrándiz C; Nagore E;
    Eur J Surg Oncol; 2020 Feb; 46(2):263-271. PubMed ID: 31594672
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histological regression in melanoma: impact on sentinel lymph node status and survival.
    Aivazian K; Ahmed T; El Sharouni MA; Stretch JR; Saw RPM; Spillane AJ; Shannon KF; Ch'ng S; Nieweg OE; Thompson JF; Lo SN; Scolyer RA
    Mod Pathol; 2021 Nov; 34(11):1999-2008. PubMed ID: 34247192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sentinel Lymph Node Biopsy Use Among Melanoma Patients 75 Years of Age and Older.
    Sabel MS; Kozminski D; Griffith K; Chang AE; Johnson TM; Wong S
    Ann Surg Oncol; 2015 Jul; 22(7):2112-9. PubMed ID: 25834993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor mitotic rate added to the equation: melanoma prognostic factors changed? : a single-institution database study on the prognostic value of tumor mitotic rate for sentinel lymph node status and survival of cutaneous melanoma patients.
    Speijers MJ; Bastiaannet E; Sloot S; Suurmeijer AJ; Hoekstra HJ
    Ann Surg Oncol; 2015 Sep; 22(9):2978-87. PubMed ID: 25605514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic role of sentinel lymph node biopsy for patients with cutaneous melanoma: A retrospective study of surveillance, epidemiology, and end-result population-based data.
    Chen J; Xu Y; Zhou Y; Wang Y; Zhu H; Shi Y
    Oncotarget; 2016 Jul; 7(29):45671-45677. PubMed ID: 27344178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transected thin melanoma: Implications for sentinel lymph node staging.
    Herbert G; Karakousis GC; Bartlett EK; Zaheer S; Graham D; Czerniecki BJ; Fraker DL; Ariyan C; Coit DG; Brady MS
    J Surg Oncol; 2018 Mar; 117(4):567-571. PubMed ID: 29194673
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
    Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
    Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictors of sentinel lymph node positivity in thin melanoma using the National Cancer Database.
    Conic RRZ; Ko J; Damiani G; Funchain P; Knackstedt T; Vij A; Vidimos A; Gastman BR
    J Am Acad Dermatol; 2019 Feb; 80(2):441-447. PubMed ID: 30240775
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sentinel lymph node biopsy in patients with thin melanomas: Frequency and predictors of metastasis based on analysis of two large international cohorts.
    Isaksson K; Nielsen K; Mikiver R; Nieweg OE; Scolyer RA; Thompson JF; Ingvar C
    J Surg Oncol; 2018 Sep; 118(4):599-605. PubMed ID: 30196533
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors for Use of Sentinel Node Biopsy and the Association with Improved Survival in Melanoma Patients Who Have Nodal Staging.
    Murtha TD; Han G; Han D
    Ann Surg Oncol; 2018 Apr; 25(4):903-911. PubMed ID: 29368153
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sentinel lymph node biopsy is a prognostic measure in pediatric melanoma.
    Kim J; Sun Z; Gulack BC; Adam MA; Mosca PJ; Rice HE; Tracy ET
    J Pediatr Surg; 2016 Jun; 51(6):986-90. PubMed ID: 27041229
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diversity of stage III melanoma in the era of sentinel lymph node biopsy.
    Egger ME; Callender GG; McMasters KM; Ross MI; Martin RC; Edwards MJ; Urist MM; Noyes RD; Sussman JJ; Reintgen DS; Stromberg AJ; Scoggins CR
    Ann Surg Oncol; 2013 Mar; 20(3):956-63. PubMed ID: 23064795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Triple-marker PCR assay of sentinel lymph node as a prognostic factor in melanoma.
    Ito T; Wada M; Nagae K; Nakano-Nakamura M; Nakahara T; Hagihara A; Furue M; Uchi H
    J Eur Acad Dermatol Venereol; 2015 May; 29(5):912-8. PubMed ID: 25199412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is the non-sentinel lymph node compartment the next site for melanoma progression from the sentinel lymph node compartment in the regional nodal basin?
    Rios-Cantu A; Lu Y; Melendez-Elizondo V; Chen M; Gutierrez-Range A; Fadaki N; Thummala S; West-Coffee C; Cleaver J; Kashani-Sabet M; Leong SPL
    Clin Exp Metastasis; 2017 Jun; 34(5):345-350. PubMed ID: 28699042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic factors in melanoma patients with tumor-negative sentinel lymph nodes.
    Egger ME; Bhutiani N; Farmer RW; Stromberg AJ; Martin RC; Quillo AR; McMasters KM; Scoggins CR
    Surgery; 2016 May; 159(5):1412-21. PubMed ID: 26775577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A nomogram to predict node positivity in patients with thin melanomas helps inform shared patient decision making.
    Friedman C; Lyon M; Torphy RJ; Thieu D; Hosokawa P; Gonzalez R; Lewis KD; Medina TM; Rioth MJ; Robinson WA; Kounalakis N; McCarter MD; Gleisner AL
    J Surg Oncol; 2019 Dec; 120(7):1276-1283. PubMed ID: 31602665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinico-pathological features of patients with melanoma and positive sentinel lymph node biopsy: a single institution experience.
    Homolak D; Šitum M; Čupić H
    Acta Dermatovenerol Croat; 2015; 23(2):122-9. PubMed ID: 26228823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sentinel lymph node biopsy in patients with thin primary cutaneous melanoma.
    Murali R; Haydu LE; Quinn MJ; Saw RP; Shannon K; Spillane AJ; Stretch JR; Thompson JF; Scolyer RA
    Ann Surg; 2012 Jan; 255(1):128-33. PubMed ID: 21975320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.